Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Fleischer

Showing results (21-30 of 48) with videos related to

Pageof 5
Sort By:
Genome Medicine|April 30, 2021
Crosstalk between microRNA expression and DNA methylation drives the hormone-dependent phenotype of breast cancerMiriam Ragle Aure, Thomas Fleischer, Sunniva Bjørklund, et al.
Heliyon|July 25, 2024
Telomere length as a predictor of therapy response and survival in patients diagnosed with ovarian carcinomaKristyna Tomasova, Karolina Seborova, Michal Kroupa, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 7, 2018
DNA Methylation of <i>LRRC3B</i>: A Biomarker for Survival of Early-Stage Non-Small Cell Lung Cancer PatientsYichen Guo, Ruyang Zhang, Sipeng Shen, et al.
Breast Cancer Research : BCR|June 24, 2022
DNA methylation changes in response to neoadjuvant chemotherapy are associated with breast cancer survivalChristine Aaserød Pedersen, Maria Dung Cao, Thomas Fleischer, et al.
Molecular Oncology|January 8, 2011
Methylation profiling with a panel of cancer related genes: association with estrogen receptor, TP53 mutation status and expression subtypes in sporadic breast cancerJo Anders Rønneberg, Thomas Fleischer, Hiroko Kato Solvang, et al.
Molecular Oncology|November 26, 2015
Genome-wide DNA methylation analyses in lung adenocarcinomas: Association with EGFR, KRAS and TP53 mutation status, gene expression and prognosisMaria Moksnes Bjaanæs, Thomas Fleischer, Ann Rita Halvorsen, et al.
Development (Cambridge, England)|August 23, 2022
PHLPP1 regulates CFTR activity and lumen expansion through AMPKViola H Lobert, Maren L Skardal, Lene Malerød, et al.
Communications Biology|August 18, 2022
Subtype and cell type specific expression of lncRNAs provide insight into breast cancerSunniva Stordal Bjørklund, Miriam Ragle Aure, Jari Häkkinen, et al.
Cancer Research|May 24, 2019
Toward Personalized Computer Simulation of Breast Cancer Treatment: A Multiscale Pharmacokinetic and Pharmacodynamic Model Informed by Multitype Patient DataXiaoran Lai, Oliver M Geier, Thomas Fleischer, et al.
Oncoimmunology|November 1, 2018
Serum cytokine levels in breast cancer patients during neoadjuvant treatment with bevacizumabShakila Jabeen, Manuela Zucknick, Marianne Nome, et al.
Pageof 5

Showing results (21-30 of 48) with videos related to

Sort By:
Pageof 5
Genome Medicine|April 30, 2021
Crosstalk between microRNA expression and DNA methylation drives the hormone-dependent phenotype of breast cancerMiriam Ragle Aure, Thomas Fleischer, Sunniva Bjørklund, et al.
Heliyon|July 25, 2024
Telomere length as a predictor of therapy response and survival in patients diagnosed with ovarian carcinomaKristyna Tomasova, Karolina Seborova, Michal Kroupa, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 7, 2018
DNA Methylation of <i>LRRC3B</i>: A Biomarker for Survival of Early-Stage Non-Small Cell Lung Cancer PatientsYichen Guo, Ruyang Zhang, Sipeng Shen, et al.
Breast Cancer Research : BCR|June 24, 2022
DNA methylation changes in response to neoadjuvant chemotherapy are associated with breast cancer survivalChristine Aaserød Pedersen, Maria Dung Cao, Thomas Fleischer, et al.
Molecular Oncology|January 8, 2011
Methylation profiling with a panel of cancer related genes: association with estrogen receptor, TP53 mutation status and expression subtypes in sporadic breast cancerJo Anders Rønneberg, Thomas Fleischer, Hiroko Kato Solvang, et al.
Molecular Oncology|November 26, 2015
Genome-wide DNA methylation analyses in lung adenocarcinomas: Association with EGFR, KRAS and TP53 mutation status, gene expression and prognosisMaria Moksnes Bjaanæs, Thomas Fleischer, Ann Rita Halvorsen, et al.
Development (Cambridge, England)|August 23, 2022
PHLPP1 regulates CFTR activity and lumen expansion through AMPKViola H Lobert, Maren L Skardal, Lene Malerød, et al.
Communications Biology|August 18, 2022
Subtype and cell type specific expression of lncRNAs provide insight into breast cancerSunniva Stordal Bjørklund, Miriam Ragle Aure, Jari Häkkinen, et al.
Cancer Research|May 24, 2019
Toward Personalized Computer Simulation of Breast Cancer Treatment: A Multiscale Pharmacokinetic and Pharmacodynamic Model Informed by Multitype Patient DataXiaoran Lai, Oliver M Geier, Thomas Fleischer, et al.
Oncoimmunology|November 1, 2018
Serum cytokine levels in breast cancer patients during neoadjuvant treatment with bevacizumabShakila Jabeen, Manuela Zucknick, Marianne Nome, et al.
Pageof 5